// App-Quantinova.ai

: HYDROXYCHLOROQUINE ON THE TOP OF STANDARD TREATMENT WITH LOW DOSE ASPIRIN AND LOW MOLECULAR WEIGHT HEPARIN SIGNIFICANTLY REDUCES THE PROBABILITY OF PREGNANCY MORBIDITY IN WOMEN WITH MULTIPLE POSITIVITY FOR ANTI-PHOSPHOLIPID ANTIBODIES

Researchers

Presenter

  • Cecilia Chighizola

Principal Investigators

  • Francesca Pregnolato

  • Francesca Bartoli

  • Maria Gerosa

  • Chiara Comerio

  • Maria Gabriella Raimondi

  • Laura Trespidi

  • Maria Orietta Borghi

  • Manuela Wally Ossola

  • Enrico Ferrazzi

  • Pier Luigi Meroni

Medical Centers

  • istituto auxologico italiano, Milano, Italy

  • University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy

  • ASST Gaetano Pini-CTO, Dept. of Rheumatology, Milano, Italy

  • Fondazione Ca’ Granda- Ospedale Maggiore Policlinico, Department of Obstet-Gynecol, Milan, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Spontaneous preterm delivery

  • Spontaneous abortion

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved